Sign in to continue:

Thursday, January 29th, 2026
Stock Profile: T14
T14 Logo

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14)


📊 Statistics




💰 Dividend History


Current year to date yield: 10.92%

2026 — Total Amount: $2.450000 | Total Yield: 10.92%
Ex Date: 2026-01-30

Amount: $2.450000

Yield: 10.92%

Pay Date: 2026-02-12

Details: Rate: CNY 2.45 Per Security

2025 — Total Amount: $1.280000 | Total Yield: 6.92%
Ex Date: 2025-06-25

Amount: $1.280000

Yield: 6.92%

Pay Date: 2025-07-04

Details: Rate: CNY 1.28 Per Security

2024 — Total Amount: $1.280000 | Total Yield: 7.38%
Ex Date: 2024-07-02

Amount: $1.280000

Yield: 7.38%

Pay Date: 2024-07-12

Details: Rate: CNY 1.28 Per Security

2023 — Total Amount: $1.120000 | Total Yield: 6.98%
Ex Date: 2023-05-26

Amount: $1.120000

Yield: 6.98%

Pay Date: 2023-06-06

Details: Rate: CNY 1.12 Per Security

2022 — Total Amount: $0.500000 | Total Yield: 6.52%
Ex Date: 2022-05-24

Amount: $0.500000

Yield: 6.52%

Pay Date: 2022-06-02

Details: Rate: CNY 0.5 Per Security



📅 SGX Earnings Announcements for T14


Date of Broadcast Title Financial Year Ended
2025-08-14 17:16 Second Quarter and/ or Half Yearly Results 2025/06/30
2025-04-29 17:17 First Quarter Results 2025/03/31
2025-03-28 20:47 Full Yearly Results 2024/12/31
2024-10-30 17:21 Third Quarter Results 2024/09/30
2024-08-14 17:56 Second Quarter and/ or Half Yearly Results 2024/06/30
2024-04-29 17:25 First Quarter Results 2024/03/31
2024-03-29 19:56 Full Yearly Results 2023/12/31
2023-10-30 18:28 Third Quarter Results 2023/09/30


Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14)

Market: SGX | Currency: USD

Address: Darentang Building

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1981 and is based in Tianjin, the People's Republic of Show more



📈 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Historical Chart




🧾 Recent Financial Statement Analysis


🔎 View more in SGX corporate News 🔎 View more in SGX Financial statements



📰 Related News & Research


Showing results matched by any of: T14, Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, TIAN SP, TIANJIN PHARMACEUTICAL DA -S, TIANJIN PHARM DA REN TANG GRP